
Opinion|Videos|September 20, 2024
AI and the Future of Biomarkers in Prostate Cancer
Prostate cancer specialists share their insights on anticipated future advancements that could significantly influence prostate cancer management strategies.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What future advancements in testing protocols do you anticipate, and how might they impact the management of prostate cancer?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Testosterone deficiency: FAQs from the AUA guideline
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5

















